Armata Pharmaceuticals, Inc. (ARMP) › Shareholders' EquityArmata Pharmaceuticals, Inc. (ARMP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: $12.94M2013: -$22.62M2014: $3.44M2015: $12.71M2016: $9.72M2017: $24.34M2018: $7.69M2019: $14.59M2020: $18.86M2021: $25.40M2022: $36.08M2023: -$32.06M2024: -$48.02M2025: -$218.60M-$218.60M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$218.60M-355.2%2024-$48.02M-49.8%2023-$32.06M-188.9%2022$36.08M+42.1%2021$25.40M+34.7%2020$18.86M+29.2%2019$14.59M+89.7%2018$7.69M-68.4%2017$24.34M+150.4%2016$9.72M-23.5%2015$12.71M+269.9%2014$3.44M+115.2%2013-$22.62M-274.8%2012$12.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share